重組蛋白

重組蛋白是解析生物相互作用的關(guān)鍵工具,廣泛應(yīng)用于各類研究實(shí)驗(yàn)中。無論是商業(yè)化產(chǎn)品,還是為特定研究定制的蛋白,它們都在多種科學(xué)應(yīng)用中發(fā)揮著不可替代的作用。
若您需要優(yōu)質(zhì)重組蛋白——已驗(yàn)證的生物活性、低內(nèi)毒素水平、高純度——來為您的研究提供可靠支持,這里正是您的理想之選。
歷經(jīng)18年積累,華美生物已構(gòu)建覆蓋原核與真核的五大蛋白質(zhì)表達(dá)系統(tǒng)。我們擁有包括桿狀病毒外膜蛋白(OMP)表達(dá)技術(shù)、膜蛋白表達(dá)技術(shù)等在內(nèi)的多項(xiàng)蛋白表達(dá)與純化專有技術(shù),致力于為您提供高質(zhì)量的重組蛋白解決方案。
產(chǎn)品特點(diǎn)
- 覆蓋廣泛:擁有超過16,000種重組蛋白,涵蓋人類、小鼠、大鼠、兔、豚鼠、雞、猴、豬等多種物種的基因與靶點(diǎn),支持跨物種比較研究。
- 表達(dá)系統(tǒng)全面:提供五大表達(dá)系統(tǒng),包括大腸桿菌、酵母、桿狀病毒-昆蟲細(xì)胞、哺乳動(dòng)物細(xì)胞以及特有的無細(xì)胞表達(dá)系統(tǒng)。該系統(tǒng)省去質(zhì)粒轉(zhuǎn)化、細(xì)胞培養(yǎng)、破碎離心等步驟,顯著提升蛋白制備效率。
- 多標(biāo)簽選擇:支持His、GST、Flag、MBP等多種標(biāo)簽,便于后續(xù)純化、檢測(cè)與功能研究。
- 多領(lǐng)域應(yīng)用:適用于抗原制備、細(xì)胞與分析、蛋白互作、藥物研發(fā)、酶活性檢測(cè)、ELISA標(biāo)準(zhǔn)品、體內(nèi)外研究、質(zhì)譜與結(jié)構(gòu)分析等廣泛場(chǎng)景。
- 無動(dòng)物源成分:我們已建立全程無動(dòng)物副產(chǎn)品接觸的重組蛋白生產(chǎn)線,確保產(chǎn)品的高純凈性與一致性,適用于對(duì)來源敏感的各類實(shí)驗(yàn)。
重組蛋白目錄
以下是所有重組蛋白的目錄。您可以在目錄中找到適合您研究的蛋白質(zhì),或在本網(wǎng)站頭部的搜索框中搜索它們。
如果您找不到您需要的重組蛋白,請(qǐng)查看華美生物蛋白定制服務(wù)。
通過選擇目標(biāo)名稱的首字母瀏覽產(chǎn)品。
| 產(chǎn)品名稱 | 貨號(hào) | 規(guī)格 |
|---|---|---|
| Recombinant Human Polyamine-modulated factor 1-binding protein 1 (PMFBP1), partial | CSB-YP840562HU CSB-EP840562HU CSB-BP840562HU CSB-MP840562HU CSB-EP840562HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Mitochondria-eating protein (SPATA18) | CSB-YP840563HU CSB-EP840563HU CSB-BP840563HU CSB-MP840563HU CSB-EP840563HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Actin-like protein 9 (ACTL9) | CSB-YP840564HU CSB-EP840564HU CSB-BP840564HU CSB-MP840564HU CSB-EP840564HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Protein FAM45A (FAM45A) | CSB-YP840565HU CSB-EP840565HU CSB-BP840565HU CSB-MP840565HU CSB-EP840565HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Protein pitchfork (PIFO) | CSB-YP840566HU CSB-EP840566HU CSB-BP840566HU CSB-MP840566HU CSB-EP840566HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Polyribonucleotide nucleotidyltransferase 1, mitochondrial (PNPT1) | CSB-YP840567HU CSB-EP840567HU CSB-BP840567HU CSB-MP840567HU CSB-EP840567HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Glutamate [NMDA] receptor subunit 3A (GRIN3A), partial | CSB-YP840568HU CSB-EP840568HU CSB-BP840568HU CSB-MP840568HU CSB-EP840568HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human CD99 antigen-like protein 2 (CD99L2), partial | CSB-YP840569HU CSB-EP840569HU CSB-BP840569HU CSB-MP840569HU CSB-EP840569HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Neuropilin and tolloid-like protein 1 (NETO1), partial | CSB-YP840571HU CSB-EP840571HU CSB-BP840571HU CSB-MP840571HU CSB-EP840571HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human BPI fold-containing family B member 1 (BPIFB1) | CSB-YP840572HU CSB-EP840572HU CSB-BP840572HU CSB-MP840572HU CSB-EP840572HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Hydroxycarboxylic acid receptor 2 (HCAR2), partial | CSB-YP840573HU1 CSB-EP840573HU1 CSB-BP840573HU1 CSB-MP840573HU1 CSB-EP840573HU1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Putative vomeronasal receptor-like protein 4 (VN1R17P), partial | CSB-YP840574HU1 CSB-EP840574HU1 CSB-BP840574HU1 CSB-MP840574HU1 CSB-EP840574HU1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Glucose-dependent insulinotropic receptor (GPR119), partial | CSB-YP840575HU1 CSB-EP840575HU1 CSB-BP840575HU1 CSB-MP840575HU1 CSB-EP840575HU1-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Serine/threonine-protein kinase Nek7 (NEK7) | CSB-YP840576HU CSB-BP840576HU CSB-MP840576HU CSB-EP840576HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Taste receptor type 1 member 2 (TAS1R2), partial | CSB-YP840577HU CSB-BP840577HU CSB-MP840577HU CSB-EP840577HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human MORC family CW-type zinc finger protein 4 (MORC4), partial | CSB-YP840578HU CSB-BP840578HU CSB-MP840578HU CSB-EP840578HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human TBC domain-containing protein kinase-like protein (TBCK), partial | CSB-YP840579HU CSB-EP840579HU CSB-BP840579HU CSB-MP840579HU CSB-EP840579HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human U3 small nucleolar RNA-associated protein 15 homolog (UTP15) | CSB-YP840580HU CSB-EP840580HU CSB-BP840580HU CSB-MP840580HU CSB-EP840580HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Short transient receptor potential channel 4-associated protein (TRPC4AP) | CSB-YP840581HU CSB-BP840581HU CSB-MP840581HU CSB-EP840581HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
| Recombinant Human Sushi, nidogen and EGF-like domain-containing protein 1 (SNED1), partial | CSB-YP840582HU CSB-EP840582HU CSB-BP840582HU CSB-MP840582HU CSB-EP840582HU-B |
20μg/100μg/1mg(1mg*1 or 500ug*2) |
有用資源
什么是重組蛋白?
重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。
第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。
第二條:如何選擇合適的表達(dá)載體?
表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。
根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。
引用資料
Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023
Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023
Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023
Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023
Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022






